Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Helix Biopharm (HBP.TO)

Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Helix Biopharma: Fiscal Q1 Earnings Snapshot

Helix Biopharma: Fiscal Q1 Earnings Snapshot

HBP.TO : 0.2100 (-4.55%)
Helix Biopharma: Fiscal Q4 Earnings Snapshot

Helix Biopharma: Fiscal Q4 Earnings Snapshot

HBP.TO : 0.2100 (-4.55%)
Stocks in play: Helix BioPharma Corp.

Will present new preclinical data on L-DOS47 in combination with PD1 checkpoint inhibition at the 2023 ...

HBP.TO : 0.2100 (-4.55%)
Helix Biopharma: Fiscal Q3 Earnings Snapshot

Helix Biopharma: Fiscal Q3 Earnings Snapshot

HBP.TO : 0.2100 (-4.55%)
Helix Biopharma: Fiscal Q2 Earnings Snapshot

Helix Biopharma: Fiscal Q2 Earnings Snapshot

HBP.TO : 0.2100 (-4.55%)
Helix Biopharma: Fiscal Q1 Earnings Snapshot

Helix Biopharma: Fiscal Q1 Earnings Snapshot

HBP.TO : 0.2100 (-4.55%)
Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.

VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp. ("Helix" or the "Company")...

HBP.TO : 0.2100 (-4.55%)
Helix Biopharma Corp. Closes Private Placement

RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology,...

HBP.TO : 0.2100 (-4.55%)
Stocks in play: Helix BioPharma Corp

Is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021. ...

HBP.TO : 0.2100 (-4.55%)
Stocks in play: Helix BioPharma Corp.

Provided a corporate update on initiatives that were undertaken by the Company in 2021. Despite the ...

HBP.TO : 0.2100 (-4.55%)

Barchart Exclusives

3 Energy Dividend Stocks to Invest in Oil's 'Higher for Longer' Scenario
Discover how Schlumberger, Baker Hughes, and Halliburton are leveraging their robust financial health and strategic initiatives to thrive in a market where oil prices are expected to remain elevated, in our latest deep dive into the energy sector's top performers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar